VDM 001
Alternative Names: VDM-001Latest Information Update: 28 Nov 2022
At a glance
- Originator VDM Biochemicals
- Class Amides; Antidotes; Antihypotensives; Drug withdrawal therapies; Piperidines; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alcoholism; Hypotension; Opioid-related disorders
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for preclinical development in Alcoholism in USA
- 28 Nov 2022 No recent reports of development identified for preclinical development in Hypotension in USA
- 28 Nov 2022 No recent reports of development identified for preclinical development in Opioid-related-disorders in USA